US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist
  • 13.0200
  • +0.3800+3.01%
Close Jul 22 16:00 ET
  • 12.8500
  • -0.1700-1.31%
Post 17:38 ET
877.94MMarket Cap-6925P/E (TTM)

Perspective Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Perspective Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 15, 2024

Revenue(YoY)

325.00K

+39.48%
EPS(YoY)

-0.20

0.00%
Analyst Rating

Strong Buy

Jun 30, 2024

Perspective Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 56.330K--
Aug 12, 20242024/Q2-- / 55.330K--
May 15, 20242024/Q1325.000K / 68.800K--
--2023/Q4-4.902M / 2.122M--
--2023/Q31.909M / 2.200M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 56.330K--
Aug 12, 20242024/Q2-- / 55.330K--
May 15, 20242024/Q1325.000K / 68.800K--
--2023/Q4-4.902M / 2.122M--
--2023/Q31.909M / 2.200M--

Unlock Free Earnings Estimates

Perspective Therapeutics Earnings Reports

  • Perspective Therapeutics | 10-Q: Quarterly report

    May 15 22:44 ET

  • Perspective Therapeutics | 10-K: Annual report

    Mar 28 08:39 ET

  • Perspective Therapeutics: Q3 2023 Earnings Report

    Nov 14, 2023 16:59 ET

  • Perspective Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 11, 2023 16:30 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg